Characterization of Choline Dehydrogenase from Pseudomonas Aeruginosa A-16

Total Page:16

File Type:pdf, Size:1020Kb

Characterization of Choline Dehydrogenase from Pseudomonas Aeruginosa A-16 Agr. Biol. Chem., 40 (10), 2077•`2084, 1976 Characterization of Choline Dehydrogenase from Pseudomonas aeruginosa A-16 Toru NAGASAWA,Nobuhiro MORI, Yoshiki TANI and Koichi OGATA Departmentof AgriculturalChemistry, Kyoto University,Kyoto ReceivedJune 11, 1976 A choline dehydrogenase, which was present in the particulate fraction of the cell-free extract of Pseudomonas aeruginosa A-16, oxidized choline to betaine aldehyde without any dissociable coenzymes, while the enzyme, which was treated with Triton X-100, oxidized choline only with a supplement of phenazine methosulfate. The difference spectrum showed the presence of cytochrome-like components in the particulate. Km values for choline and phenazine methosulfate were 1.7•~10-3M and 1.4•~10-4M, respectively. The dehydrogenase was inhibited by SH-reagents such as p-chloromercuribenzoate and iodoacetic acid. Of a variety of substrates tested, only choline caused the enzymatic reduction of phenazine metho sulfate. The estimation of choline was tried using the enzyme. It has been known that choline is metabo ƒÊ moles of potassium phosphate buffer (pH 7.4), 3.0 lized to betaine via betaine aldehyde by choline ƒÊ moles of potassium cyanide, 0.29 ƒÊmole of DCPIP dehydrogenase (EC 1.1.99.1) and betaine and an appropriate amount of enzyme. Standard assay of enzyme activity was performed with 0.7 ƒÊmole aldehyde dehydrogenase (EC 1.2.1.8) in mito of PMS and the assay was started by the addition of chondria of mammalian liver. Since the 100 ƒÊmoles of choline chloride. The decrease in ab initial study of Bernheim and Bernheim,1„ sorbance at 600nm was followed. The enzyme assay ,2) the oxidation of choline has been studied only was performed at 30°C in a Hitachi double beam with a mammalian liver. spectrophotometer model 124. The extinction co Recently, we showed that the bacterial efficient for oxidized DCPIP at 600 nm was taken to be 21.5•~l03 liter-mol-1•.cm-1.4) The initial reaction choline dehydrogenase was present in the velocity was proportional to enzyme concentration up particulate fraction of the cell-free extracts of to a velocity of at least 0.18 ƒÊmole of DCPIP/min and Pseudomonas aeruginosa A-16.3) In this paper, the progress curve was linear with time for the first the characterization of the bacterial choline minute throughout this range. The unit of enzyme dehydrogenase will be described. activity is defined as being the amount of enzyme that catalyzes the reduction of 1 ƒÊmole of DCPIP/min under the standard assay conditions. Specific ac MATERIALS AND METHODS tivity was defined as the units per mg of protein. Materials. 3-(4,5-Dimethylthiazolyl-2)-2,5-di Protein determination. Protein was determined by phenyltetrazolium bromide (MTT) was purchased from the procedure of Lowry et al.,3) or from the absorbance Sigma Co. NAD, NADP and yeast extract were ob at 280 nm with the assumption of E0.1 1cm=1.0. tained from the Oriental Yeast CO., Cytochrome c (horse heart) was purchased from the Boehringer Co., Partial purification of the enzyme. The following Mannheim. Peptone, meat extract and casamino acid buffer mixtures were used: A, 0.01M potassium were obtained from Daigo Co., Ltd., Mikuni Co., Ltd. phosphate buffer (pH 7.4) containing 0.001% 2- and Difco Laboratory, respectively. All other com mercaptoethanol and 1mM EDTA; B, buffer A con pounds were of reagent grade and from commercial taining 10% glycerol. All procedures were performed sources. at 0•`5•Ž. Unless otherwise stated, centrifugation was carried out for 20 min at 12,000xg. Choline dehydrogenase assay. Phenazine metho sulfate (PMS)-2,6-dichlorophenol-indophenol (DCPIP) 1. Preparation of the particulate enzyme. The assay system was used in this study, unless otherwise particulate enzyme was prepared as described in a stated. The assay medium (2.74ml) contained 125 previous paper.3) The specific activity was 5.73x 2078 T. NAGASAWA, N. MORI, Y. TANI and K. OGATA 10-3, and it was stored at -20•Ž for several months RESULTS without loss of activity. Identification of reduction product 2. Triton treatment. To the preparation from 1, Triton X-100 was added to a final concentration of The reaction mixture (20ml) containing 0.3%. with stirring. After the incubation for 30 min 100mg of choline chloride, 200ƒÊmoles of at 25•Ž, the solution was centrifuged at 100,000xg for potassium phosphate buffer (pH 7.4) and 2 60 min and gelatious precipitates were removed. The units of particulate enzyme was incubated for choline dehydrogenase almost appeared in the red and 6hr at 25•Ž with constant shaking. The deri transparent supernatant solution (specific activity: vative of the reaction product prepared ac 6.86•~10-3). The supernatant was dialyzed against the buffer B for 15 hr. cording to Jellinek's method6) was dissolved in ethanol and crystallized by the addition of 3. Chloroform treatment. To the dialysate from water. After three recrystallization, the. pro 2, precooled chloroform was added with vigorous duct showed the melting point of 178•`180•Ž stirring to a final concentration of 33%. The tubid solution was stirred for 20min, and centrifuged at (lit. mp 181•`183•Ž).6) The formula, 6,000xg. The aqueous solution was dialyzed for 15 hr C17H17011N8 was calculated from the analytical against buffer B, and then concentrated by Sephadex results (calcd: C 40.00, H 3.53, Picric acid G-50 and ultrafiltration (specific activity: 14.6•~ 10-3). 44.7; found: C 39.80, H 3.62, Picric acid 45.00). Thus, the reaction product was 4. Sepharose 6B column chromatography. The concentrated enzyme solution (2.0ml) was placed on a identified as the picrate of 2,4-dinitrophenyl- Sepharose 6B (2.5•~73cm) column which had been hydrazone of betaine aldehyde. equilibrated with 0.01M buffer B containing 0.1M NaCI and eluted with the same buffer at a flow rate of Electron carrier requirements for choline oxida 13ml/hr. Active fractions with a specific activity of 14.6•~10-3 were combined and concentrated by Sepha- tion dex G-50 and ultrafiltration. The enzyme solution was As shown in Fig. 2, the particulate enzyme rechromatographed on the same column under the formed betaine aldehyde without requiring same condition. A typical elution profile is shown in any dissociable coenzymes. The addition of Fig. 1. After active fractions above specific activity of 14.9 were combined and concentrated, the enzyme potassium cyanide thoroughly inhibited the solution (specific activity: 15.1•~10-3) was used as the formation of betaine aldehyde at the final partially purified enzyme in this study. concentration of 1 mm. In contrast, Triton treated enzyme did not catalyze the choline oxidation. The enzyme exhibited its catalytic activity by an addition of PMS. The choline oxidation in the presence of PMS was insensi tive to potassium cyanide. The relative ac tivities with several electron acceptors in the particulate enzyme or the purified enzyme were compared (Table I). The reaction of the particulate enzyme with ferricyanide was con siderably significant, and the reaction with externally added DCPIP, MTT or cytochrome c measured only a part of the activity, and that with NAD and NADP is almost negligible. The reactions of Triton-treated enzyme with additions of ferricyanide, DCPIP , MTT and cytochrome c were completely abolished. FIG. 1. Elution Diagram of the Fractionation of The reactivity of choline dehydrogenase with Bacterial Choline Dehydrogenase on Sepharose 6B . PMS was fully retained under these condi •œ, absorbance at 280 nm; •›, enzyme activity . tions. Bacterial Choline Dehydrogenase 2079 TABLE I. RELATIVE RATES OF CHOLINE OXIDATION WITH SEVERAL ELECTRON ACCEPTORS The specific activities of particulate enzyme and Triton-treated enzyme used in this experiment were 7.76•~10-3 and 14.5•~10-3, respectively, in the stand ard assay of PMS-DCPIP system. All measurements were based on initial rate and were calculated as moles of electron acceptors reduced per min per mg of protein. Rates were Vmax. PMS assay was car ried out under the standard condition. Ferricyanide assay was carried out by following the decrease in absorbance at 420nm. To the mixture (2.7ml) con taining 125 ƒÊmoles of potassium phosphate buffer FIG. 2. Time Course of Betaine Aldehyde Forma (pH 7.4), 7.9 ƒÊmoles of potassium ferricyanide and tion by Choline Dehydrogenase. 100 ƒÊmoles of choline chloride, an appropriate amount The formation of betaine aldehyde was measured as of enzyme was added. The extinction coefficient for its 2,4-dinitrophenylhydrazone according to Jellinek's oxidized ferricyanide at 420nm was taken to be method.8) Reactions were catalyzed by 6.28mg of 1.02•~103 liter-mol-1. cm-1.7) DCPIP, MTT, cyto chrome c and NAD(P) as primary electron acceptor particulate enzyme (specific activity: 5.73•~10-3) or 4.15mg of Triton-treated enzyme (specific activity: were tested in the assay medium (2.74ml) containing 6.87•~10-3) in the reaction mixture (5.0ml) contain 125 ƒÊmoles of potassium phosphate buffer (pH 7.4), ing 208 ƒÊmoles of potassium phosphate buffer (pH 3.0 ƒÊmoles of potassium cyanide, 0.29•`1 ƒÊmole of 7.4), 189 ƒÊmoles of choline chloride. Phenazine primary electron acceptor, and an appropriate amount methosulfate and potassium cyanide were added to of enzyme. The assays were started by the addition the reaction mixture at the concentration of 0.42mM of 100 ƒÊmoles of choline chloride. Reaction rates and 1mM, respectively.•›•\•› were assayed at 600,550 and 340nm, respectively.7,8) , (A) particulate choline dehydrogenase. (B) particulate choline dehydrogenase+potassium cyanide. •œ•\•œ , (C) Triton-treated choline dehydrogenase. (D) Triton-treated choline dehydrogenase+phenazine methosulfate. Reduction of cytochrome in particulate by choline The difference spectrum of particulate en zyme between the presence and the absence of choline showed the absorption maxima at 559nm, 520•`528nm and 427nm, which CDH* : choline dehydrogenase activity.
Recommended publications
  • The Role of Genetic Variation in Predisposition to Alcohol-Related Chronic Pancreatitis
    The Role of Genetic Variation in Predisposition to Alcohol-related Chronic Pancreatitis Thesis submitted in accordance with the requirements of the University of Liverpool for the degree of Doctor in Philosophy by Marianne Lucy Johnstone April 2015 The Role of Genetic Variation in Predisposition to Alcohol-related Chronic Pancreatitis 2015 Abstract Background Chronic pancreatitis (CP) is a disease of fibrosis of the pancreas for which alcohol is the main causative agent. However, only a small proportion of alcoholics develop chronic pancreatitis. Genetic polymorphism may affect pancreatitis risk. Aim To determine the factors required to classify a chronic pancreatic population and identify genetic variations that may explain why only some alcoholics develop chronic pancreatitis. Methods The most appropriate method of diagnosing CP was assessed using a systematic review. Genetics of different populations of alcohol-related chronic pancreatitics (ACP) were explored using four different techniques: genome-wide association study (GWAS); custom arrays; PCR of variable nucleotide tandem repeats (VNTR) and next generation sequencing (NGS) of selected genes. Results EUS and sMR were identified as giving the overall best sensitivity and specificity for diagnosing CP. GWAS revealed two associations with CP (identified and replicated) at PRSS1-PRSS2_rs10273639 (OR 0.73, 95% CI 0.68-0.79) and X-linked CLDN2_rs12688220 (OR 1.39, 1.28-1.49) and the association was more pronounced in the ACP group (OR 0.56, 0.48-0.64)and OR 2.11, 1.84-2.42). The previously identified VNTR in CEL was shown to have a lower frequency of the normal repeat in ACP than alcoholic liver disease (ALD; OR 0.61, 0.41-0.93).
    [Show full text]
  • Enzyme DHRS7
    Toward the identification of a function of the “orphan” enzyme DHRS7 Inauguraldissertation zur Erlangung der Würde eines Doktors der Philosophie vorgelegt der Philosophisch-Naturwissenschaftlichen Fakultät der Universität Basel von Selene Araya, aus Lugano, Tessin Basel, 2018 Originaldokument gespeichert auf dem Dokumentenserver der Universität Basel edoc.unibas.ch Genehmigt von der Philosophisch-Naturwissenschaftlichen Fakultät auf Antrag von Prof. Dr. Alex Odermatt (Fakultätsverantwortlicher) und Prof. Dr. Michael Arand (Korreferent) Basel, den 26.6.2018 ________________________ Dekan Prof. Dr. Martin Spiess I. List of Abbreviations 3α/βAdiol 3α/β-Androstanediol (5α-Androstane-3α/β,17β-diol) 3α/βHSD 3α/β-hydroxysteroid dehydrogenase 17β-HSD 17β-Hydroxysteroid Dehydrogenase 17αOHProg 17α-Hydroxyprogesterone 20α/βOHProg 20α/β-Hydroxyprogesterone 17α,20α/βdiOHProg 20α/βdihydroxyprogesterone ADT Androgen deprivation therapy ANOVA Analysis of variance AR Androgen Receptor AKR Aldo-Keto Reductase ATCC American Type Culture Collection CAM Cell Adhesion Molecule CYP Cytochrome P450 CBR1 Carbonyl reductase 1 CRPC Castration resistant prostate cancer Ct-value Cycle threshold-value DHRS7 (B/C) Dehydrogenase/Reductase Short Chain Dehydrogenase Family Member 7 (B/C) DHEA Dehydroepiandrosterone DHP Dehydroprogesterone DHT 5α-Dihydrotestosterone DMEM Dulbecco's Modified Eagle's Medium DMSO Dimethyl Sulfoxide DTT Dithiothreitol E1 Estrone E2 Estradiol ECM Extracellular Membrane EDTA Ethylenediaminetetraacetic acid EMT Epithelial-mesenchymal transition ER Endoplasmic Reticulum ERα/β Estrogen Receptor α/β FBS Fetal Bovine Serum 3 FDR False discovery rate FGF Fibroblast growth factor HEPES 4-(2-Hydroxyethyl)-1-Piperazineethanesulfonic Acid HMDB Human Metabolome Database HPLC High Performance Liquid Chromatography HSD Hydroxysteroid Dehydrogenase IC50 Half-Maximal Inhibitory Concentration LNCaP Lymph node carcinoma of the prostate mRNA Messenger Ribonucleic Acid n.d.
    [Show full text]
  • Serum Albumin OS=Homo Sapiens
    Protein Name Cluster of Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 (P14136) Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 Cluster of Isoform 3 of Plectin OS=Homo sapiens GN=PLEC (Q15149-3) Cluster of Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 (P68871) Vimentin OS=Homo sapiens GN=VIM PE=1 SV=4 Cluster of Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 (Q13509) Cluster of Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 (P60709) Cluster of Tubulin alpha-1B chain OS=Homo sapiens GN=TUBA1B PE=1 SV=1 (P68363) Cluster of Isoform 2 of Spectrin alpha chain, non-erythrocytic 1 OS=Homo sapiens GN=SPTAN1 (Q13813-2) Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 Cluster of Spectrin beta chain, non-erythrocytic 1 OS=Homo sapiens GN=SPTBN1 PE=1 SV=2 (Q01082) Cluster of Pyruvate kinase isozymes M1/M2 OS=Homo sapiens GN=PKM PE=1 SV=4 (P14618) Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 Clathrin heavy chain 1 OS=Homo sapiens GN=CLTC PE=1 SV=5 Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 Cytoplasmic dynein 1 heavy chain 1 OS=Homo sapiens GN=DYNC1H1 PE=1 SV=5 Cluster of ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide OS=Homo sapiens GN=ATP1A2 PE=3 SV=1 (B1AKY9) Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 Dihydropyrimidinase-related protein 2 OS=Homo sapiens GN=DPYSL2 PE=1 SV=1 Cluster of Alpha-actinin-1 OS=Homo sapiens GN=ACTN1 PE=1 SV=2 (P12814) 60 kDa heat shock protein, mitochondrial OS=Homo
    [Show full text]
  • Supplementary Materials
    Supplementary Materials COMPARATIVE ANALYSIS OF THE TRANSCRIPTOME, PROTEOME AND miRNA PROFILE OF KUPFFER CELLS AND MONOCYTES Andrey Elchaninov1,3*, Anastasiya Lokhonina1,3, Maria Nikitina2, Polina Vishnyakova1,3, Andrey Makarov1, Irina Arutyunyan1, Anastasiya Poltavets1, Evgeniya Kananykhina2, Sergey Kovalchuk4, Evgeny Karpulevich5,6, Galina Bolshakova2, Gennady Sukhikh1, Timur Fatkhudinov2,3 1 Laboratory of Regenerative Medicine, National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of Russian Federation, Moscow, Russia 2 Laboratory of Growth and Development, Scientific Research Institute of Human Morphology, Moscow, Russia 3 Histology Department, Medical Institute, Peoples' Friendship University of Russia, Moscow, Russia 4 Laboratory of Bioinformatic methods for Combinatorial Chemistry and Biology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia 5 Information Systems Department, Ivannikov Institute for System Programming of the Russian Academy of Sciences, Moscow, Russia 6 Genome Engineering Laboratory, Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region, Russia Figure S1. Flow cytometry analysis of unsorted blood sample. Representative forward, side scattering and histogram are shown. The proportions of negative cells were determined in relation to the isotype controls. The percentages of positive cells are indicated. The blue curve corresponds to the isotype control. Figure S2. Flow cytometry analysis of unsorted liver stromal cells. Representative forward, side scattering and histogram are shown. The proportions of negative cells were determined in relation to the isotype controls. The percentages of positive cells are indicated. The blue curve corresponds to the isotype control. Figure S3. MiRNAs expression analysis in monocytes and Kupffer cells. Full-length of heatmaps are presented.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Metabolic Targets of Coenzyme Q10 in Mitochondria
    antioxidants Review Metabolic Targets of Coenzyme Q10 in Mitochondria Agustín Hidalgo-Gutiérrez 1,2,*, Pilar González-García 1,2, María Elena Díaz-Casado 1,2, Eliana Barriocanal-Casado 1,2, Sergio López-Herrador 1,2, Catarina M. Quinzii 3 and Luis C. López 1,2,* 1 Departamento de Fisiología, Facultad de Medicina, Universidad de Granada, 18016 Granada, Spain; [email protected] (P.G.-G.); [email protected] (M.E.D.-C.); [email protected] (E.B.-C.); [email protected] (S.L.-H.) 2 Centro de Investigación Biomédica, Instituto de Biotecnología, Universidad de Granada, 18016 Granada, Spain 3 Department of Neurology, Columbia University Medical Center, New York, NY 10032, USA; [email protected] * Correspondence: [email protected] (A.H.-G.); [email protected] (L.C.L.); Tel.: +34-958-241-000 (ext. 20197) (L.C.L.) Abstract: Coenzyme Q10 (CoQ10) is classically viewed as an important endogenous antioxidant and key component of the mitochondrial respiratory chain. For this second function, CoQ molecules seem to be dynamically segmented in a pool attached and engulfed by the super-complexes I + III, and a free pool available for complex II or any other mitochondrial enzyme that uses CoQ as a cofactor. This CoQ-free pool is, therefore, used by enzymes that link the mitochondrial respiratory chain to other pathways, such as the pyrimidine de novo biosynthesis, fatty acid β-oxidation and amino acid catabolism, glycine metabolism, proline, glyoxylate and arginine metabolism, and sulfide oxidation Citation: Hidalgo-Gutiérrez, A.; metabolism. Some of these mitochondrial pathways are also connected to metabolic pathways González-García, P.; Díaz-Casado, in other compartments of the cell and, consequently, CoQ could indirectly modulate metabolic M.E.; Barriocanal-Casado, E.; López-Herrador, S.; Quinzii, C.M.; pathways located outside the mitochondria.
    [Show full text]
  • Microrna-Mediated Metabolic Reprograming in Renal Cancer
    cancers Article MicroRNA-Mediated Metabolic Reprograming in Renal Cancer Joanna Bogusławska 1 , Piotr Popławski 1, Saleh Alseekh 2,3, Marta Koblowska 4,5 , 4,5 1 1, 1 Roksana Iwanicka-Nowicka , Beata Rybicka , Hanna K˛edzierska y, Katarzyna Głuchowska , Karolina Hanusek 1, Zbigniew Ta´nski 6, Alisdair R. Fernie 2,3 and Agnieszka Piekiełko-Witkowska 1,* 1 Department of Biochemistry and Molecular Biology, Centre of Postgraduate Medical Education, ul. Marymoncka 99/103, 01-813 Warsaw, Poland; [email protected] (J.B.); [email protected] (P.P.); [email protected] (B.R.); [email protected] (H.K.); [email protected] (K.G.); [email protected] (K.H.) 2 Max-Planck Institute of Molecular Plant Physiology, 14476 Potsdam-Golm, Germany; [email protected] (S.A.); [email protected] (A.R.F.) 3 Center for Plant Systems Biology and Biotechnology, 4000 Plovdiv, Bulgaria 4 Laboratory of Systems Biology, Faculty of Biology, University of Warsaw, 02-106 Warsaw, Poland; [email protected] (M.K.); [email protected] (R.I.-N.) 5 Laboratory for Microarray Analysis, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 02-106 Warsaw, Poland 6 Masovian Specialist Hospital in Ostroleka, 07-410 Ostroleka, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-22-5693810 Present affiliation of HK: Laboratory of Experimental Medicine, Centre of New Technologies, University of y Warsaw, 02-097 Warsaw, Poland. Received: 25 October 2019; Accepted: 15 November 2019; Published: 20 November 2019 Abstract: Metabolic reprogramming is one of the hallmarks of renal cell cancer (RCC).
    [Show full text]
  • Physiology and Biochemistry of Aromatic Hydrocarbon-Degrading Bacteria That Use Chlorate And/Or Nitrate As Electron Acceptor
    Invitation for the public defense of my thesis Physiology and biochemistry of aromatic hydrocarbon-degrading of aromatic and biochemistry Physiology bacteria that use chlorate and/or nitrate as electron acceptor as electron nitrate and/or use chlorate that bacteria Physiology and biochemistry Physiology and biochemistry of aromatic hydrocarbon-degrading of aromatic hydrocarbon- degrading bacteria that bacteria that use chlorate and/or nitrate as electron acceptor use chlorate and/or nitrate as electron acceptor The public defense of my thesis will take place in the Aula of Wageningen University (Generall Faulkesweg 1, Wageningen) on December 18 2013 at 4:00 pm. This defense is followed by a reception in Café Carré (Vijzelstraat 2, Wageningen). Margreet J. Oosterkamp J. Margreet Paranimphs Ton van Gelder ([email protected]) Aura Widjaja Margreet J. Oosterkamp ([email protected]) Marjet Oosterkamp (911 W Springfield Ave Apt 19, Urbana, IL 61801, USA; [email protected]) Omslag met flap_MJOosterkamp.indd 1 25-11-2013 5:58:31 Physiology and biochemistry of aromatic hydrocarbon-degrading bacteria that use chlorate and/or nitrate as electron acceptor Margreet J. Oosterkamp Thesis-MJOosterkamp.indd 1 25-11-2013 6:42:09 Thesis committee Thesis supervisor Prof. dr. ir. A. J. M. Stams Personal Chair at the Laboratory of Microbiology Wageningen University Thesis co-supervisors Dr. C. M. Plugge Assistant Professor at the Laboratory of Microbiology Wageningen University Dr. P. J. Schaap Assistant Professor at the Laboratory of Systems and Synthetic Biology Wageningen University Other members Prof. dr. L. Dijkhuizen, University of Groningen Prof. dr. H. J. Laanbroek, University of Utrecht Prof.
    [Show full text]
  • Inactivation of Choline Oxidase by Irreversible Inhibitors Or Storage Conditions
    Georgia State University ScholarWorks @ Georgia State University Chemistry Theses Department of Chemistry 8-3-2006 Inactivation of Choline Oxidase by Irreversible Inhibitors or Storage Conditions Jane Vu Hoang [email protected] Follow this and additional works at: https://scholarworks.gsu.edu/chemistry_theses Recommended Citation Hoang, Jane Vu, "Inactivation of Choline Oxidase by Irreversible Inhibitors or Storage Conditions." Thesis, Georgia State University, 2006. https://scholarworks.gsu.edu/chemistry_theses/4 This Thesis is brought to you for free and open access by the Department of Chemistry at ScholarWorks @ Georgia State University. It has been accepted for inclusion in Chemistry Theses by an authorized administrator of ScholarWorks @ Georgia State University. For more information, please contact [email protected]. INACTIVATION OF CHOLINE OXIDASE BY IRREVERSIBLE INHIBITORS OR STORAGE CONDITIONS by JANE V. HOANG Under the Direction of Giovanni Gadda ABSTRACT Choline oxidase from Arthrobacter globiformis is a flavin-dependent enzyme that catalyzes the oxidation of choline to betaine aldehyde through two sequential hydride-transfer steps. The study of this enzyme is of importance to the understanding of glycine betaine biosynthesis found in pathogenic bacterial or economic relevant crop plants as a response to temperature and salt stress in adverse environment. In this study, chemical modification of choline oxidase using two irreversible inhibitors, tetranitromethane and phenylhydrazine, was performed in order to gain insights into the active site structure of the enzyme. Choline oxidase can also be inactivated irreversibly by freezing in 20 mM sodium phosphate and 20 mM sodium pyrophosphate at pH 6 and -20 oC. The results showed that enzyme inactivation was due to a localized conformational change associated with the ionization of a group in close proximity to the flavin cofactor and led to a complete lost of catalytic activity.
    [Show full text]
  • Purification and Characterization of Choline Oxidase from Arthrobacter Globiformis
    J. Biochem. 82, 1741-1749 (1977) Purification and Characterization of Choline Oxidase from Arthrobacter globiformis Shigeru IKUTA, Shigeyuki IMAMURA, Hideo MISAKI, and Yoshifumi HORIUTI Research Laboratory, Toyo Jozo Co., Ltd., Mifuku, Ohito-cho, Tagata-gun, Shizuoka 410-23 Received for publication, June 7, 1977 Choline oxidase was purified from the cells of Arthrobacter globiformis by fractionations with acetone and ammonium sulfate, and column chromatographies on DEAE-cellulose and on Sephadex G-200. The purified enzyme preparation appeared homogeneous on disc gel electrophoresis. The enzyme was a flavoprotein having a molecular weight of approx. 83,000 (gel filtration) or approx. 71,000 (sodium dodecyl sulfate-polyacrylamide disc gel electro phoresis) and an isoelectric point (pl) around pH 4.5. Identification of the reaction products showed that the enzyme catalyzed the following reactions: choline+02betaine aldehyde+ H202, betaine aldehyde+02+H2O-betaine+H202. The enzyme was highly specific for choline and betaine aldehyde (relative reaction veloc ities: choline, 100%; betaine aldehyde, 46%; N,N-dimethylaminoethanol, 5.2%; triethanol amine, 2.6%; diethanolamine, 0.8%; monoethanolamine, N-methylaminoethanol, methanol, ethanol, propanol, formaldehyde, acetaldehyde, and propionaldehyde, 0%). Its Km values were 1.2 mM for choline and 8.7 mM for betaine aldehyde. The optimum pH for the enzymic reaction was around pH 7.5. In a previous report from this laboratory (1), the existence of choline oxidase was discussed in relation MATERIALS AND METHODS to the oxidative pathway of choline to betaine found in A. globiformis cells. The enzyme ap Culture of the Bacterium-Cells of A. glo peared to catalyze the oxidations of both choline biformis were grown aerobically in culture medium and betaine aldehyde coupled with H202 generation for 40 h, as described previously (1).
    [Show full text]
  • O O2 Enzymes Available from Sigma Enzymes Available from Sigma
    COO 2.7.1.15 Ribokinase OXIDOREDUCTASES CONH2 COO 2.7.1.16 Ribulokinase 1.1.1.1 Alcohol dehydrogenase BLOOD GROUP + O O + O O 1.1.1.3 Homoserine dehydrogenase HYALURONIC ACID DERMATAN ALGINATES O-ANTIGENS STARCH GLYCOGEN CH COO N COO 2.7.1.17 Xylulokinase P GLYCOPROTEINS SUBSTANCES 2 OH N + COO 1.1.1.8 Glycerol-3-phosphate dehydrogenase Ribose -O - P - O - P - O- Adenosine(P) Ribose - O - P - O - P - O -Adenosine NICOTINATE 2.7.1.19 Phosphoribulokinase GANGLIOSIDES PEPTIDO- CH OH CH OH N 1 + COO 1.1.1.9 D-Xylulose reductase 2 2 NH .2.1 2.7.1.24 Dephospho-CoA kinase O CHITIN CHONDROITIN PECTIN INULIN CELLULOSE O O NH O O O O Ribose- P 2.4 N N RP 1.1.1.10 l-Xylulose reductase MUCINS GLYCAN 6.3.5.1 2.7.7.18 2.7.1.25 Adenylylsulfate kinase CH2OH HO Indoleacetate Indoxyl + 1.1.1.14 l-Iditol dehydrogenase L O O O Desamino-NAD Nicotinate- Quinolinate- A 2.7.1.28 Triokinase O O 1.1.1.132 HO (Auxin) NAD(P) 6.3.1.5 2.4.2.19 1.1.1.19 Glucuronate reductase CHOH - 2.4.1.68 CH3 OH OH OH nucleotide 2.7.1.30 Glycerol kinase Y - COO nucleotide 2.7.1.31 Glycerate kinase 1.1.1.21 Aldehyde reductase AcNH CHOH COO 6.3.2.7-10 2.4.1.69 O 1.2.3.7 2.4.2.19 R OPPT OH OH + 1.1.1.22 UDPglucose dehydrogenase 2.4.99.7 HO O OPPU HO 2.7.1.32 Choline kinase S CH2OH 6.3.2.13 OH OPPU CH HO CH2CH(NH3)COO HO CH CH NH HO CH2CH2NHCOCH3 CH O CH CH NHCOCH COO 1.1.1.23 Histidinol dehydrogenase OPC 2.4.1.17 3 2.4.1.29 CH CHO 2 2 2 3 2 2 3 O 2.7.1.33 Pantothenate kinase CH3CH NHAC OH OH OH LACTOSE 2 COO 1.1.1.25 Shikimate dehydrogenase A HO HO OPPG CH OH 2.7.1.34 Pantetheine kinase UDP- TDP-Rhamnose 2 NH NH NH NH N M 2.7.1.36 Mevalonate kinase 1.1.1.27 Lactate dehydrogenase HO COO- GDP- 2.4.1.21 O NH NH 4.1.1.28 2.3.1.5 2.1.1.4 1.1.1.29 Glycerate dehydrogenase C UDP-N-Ac-Muramate Iduronate OH 2.4.1.1 2.4.1.11 HO 5-Hydroxy- 5-Hydroxytryptamine N-Acetyl-serotonin N-Acetyl-5-O-methyl-serotonin Quinolinate 2.7.1.39 Homoserine kinase Mannuronate CH3 etc.
    [Show full text]
  • Method and Reagent for Determination of Dehydrogenase Or Its Substrate
    Europaisches Patentamt 3 European Patent Office © Publication number: 0 285 998 Office europeen des brevets A2 EUROPEAN PATENT APPLICATION @ number: Application 88105172.6 © mt.ci.«:C12Q 1/32 , C12Q 1/28 @ Date of filing: 30.03.88 ® Priority: 02.04.87 JP 82277/87 <O Applicant: Toyo Boseki Kabushiki Kaisha No 8, Dojimahamadouri 2-chome Kita-ku @ Date of publication of application: Osaka-shi, Osaka-fu(JP) 12.10.88 Bulletin 88/41 © Inventor: Asano, Shigeki ® Designated Contracting States: 9-4, Toyo-cho DE FR IT Tsuruga-shi Fukui-ken(JP) Inventor: Watanabe, Haruo 9-2-301, Toyo-cho Tsuruga-shi Fukui-ken(JP) Inventor: Hayashi, Yuzo 14-20-119, Kusunoki-cho Ashiya-shi Hyogo-ken(JP) 0 Representative: Vossius & Partner Siebertstrasse 4 P.O. Box 86 07 67 D-8000 Munchen 86(DE) ® Method and reagent for determination of dehydrogenase or its substrate. © A method for determining dehydrogenase or its substrate in dehydrogenase reaction, which comprises subjecting a dehydrogenase and its substrate to a dehydrogenase reaction in the presence of an electron carrier or a combination of a coenzyme and an electron carrier, allowing to form H2O2 through transfer of electrons derived from the substrate by the dehydrogenase reaction to O2 via the electron carrier or via the coenzyme and electron carrier, stopping the dehydrogenase reaction, reacting said H2O2 with a peroxidase and a chromogen, and measuring a formed dye, and a reagent for determining dehydrogenase or its substrate. By the method and the reagent, dehydrogenase or its substrate can be accurately determined in a short time regardless of the concentration of the dehydrogenase and/or the substrate and without staining tubes or cells of a determination device with a dye.
    [Show full text]